Interventional Radiology - Original Article

Transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma: response analysis with mRECIST
  • Claudia Domaratius
  • Utz Settmacher
  • Christina Malessa
  • Ulf Teichgräber
Diagn Interv Radiol 2021; 27: 85-93 DOI: 10.5152/dir.2020.19439
Multiple imaging modality-guided radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma in special locations
  • Bo-Shuai Yang
  • Ling-Xiao Liu
  • Min Yuan
  • Yi-Bin Hou
  • Qing-Tao Li
  • Su Zhou
  • Yu-Xin Shi
  • Bu-Lang Gao
Diagn Interv Radiol 2020; 26: 131-139 DOI: 10.5152/dir.2019.18540
mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization
  • Hippocrates Moschouris
  • Katerina Malagari
  • Marina G. Papadaki
  • Ioannis Kornezos
  • Konstantinos Stamatiou
  • Antonios Anagnostopoulos,
  • Katerina Chatzimichael
  • Nikolaos Kelekis
Diagn Interv Radiol 2014; 20: 136-142 DOI: 10.5152/dir.2013.13282
Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma
  • Rusi Zhang
  • Lujun Shen
  • Long Zhao
  • Zhaoming Guan
  • Qifeng Chen
  • Wang Li
Diagn Interv Radiol 2018; 24: 219-224 DOI: 10.5152/dir.2018.17528
Drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma: does size really matter?
  • Sieh-Yang Lee
  • Hsin-You Ou
  • Chun-Yen Yu
  • Tung-Liang Huang
  • Leo Leung-Chit Tsang
  • Yu-Fan Cheng
Diagn Interv Radiol 2020; 26: 230-235 DOI: 10.5152/dir.2019.19261
Usefulness of fusion images of unenhanced and contrast-enhanced arterial phase cone-beam CT in the detection of viable hepatocellular carcinoma during transarterial chemoembolization
  • Eu Hyun Kim
  • Jung Suk Oh
  • Ho Jong Chun
  • Byung Gil Choi
  • Hae Giu Lee
Diagn Interv Radiol 2018; 24: 262-267 DOI: 10.5152/dir.2018.17503
The effect of using different embolic agents on survival in transarterial chemoembolization of hepatocellular carcinoma: gelfoam versus polyvinyl alcohol
  • Ali Koçyiğit
  • Oğuz Dicle
  • Yiğit Göktay
  • İbrahim Astarcıoğlu
Diagn Interv Radiol 2014; 20: 323-329 DOI: 10.5152/dir.2014.13462
Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model
  • Max Seidensticker
  • Sebastian Streit
  • Norbert Nass
  • Christian Wybranski
  • Julian Jürgens
  • Jan Brauner
  • Nadine Schulz
  • Thomas Kalinski
  • Ricarda Seidensticker
  • Benjamin Garlipp
  • Ingo Steffen
  • Jens Ricke
  • Oliver Dudeck
Diagn Interv Radiol 2016; 22: 378-384 DOI: 10.5152/dir.2016.15462
Does neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization improve survival in patients undergoing liver transplant for hepatocellular carcinoma?
  • Dimitri Dorcaratto
  • Venkatesha Udupa
  • Niamh M. Hogan
  • David P. Brophy
  • Jeffrey W. McCann
  • Donal Maguire
  • Justin Geoghegan
  • Colin P. Cantwell
  • Emir Hoti
Diagn Interv Radiol 2017; 23: 441-447 DOI: 10.5152/dir.2017.17106
Dual-balloon infusion microcatheter for selective drug-eluting bead transarterial chemoembolization: initial feasibility study
  • Wayne L. Monsky
  • Siddharth A. Padia
  • Andrew Hal Hardy
Diagn Interv Radiol 2017; 23: 454-460 DOI: 10.5152/dir.2017.17059
Super-selective transarterial chemoembolization of hepatocellular carcinoma with doxorubicin-eluting beads sized 40–75 microns: assessment of efficacy and safety
  • Hüseyin Tuğsan Ballı
  • Kairgeldy Aikimbaev
Diagn Interv Radiol 2020; 26: 482-487 DOI: 10.5152/dir.2020.19410
Retrograde venous coil embolization prior to transarterial chemoembolization in hepatocellular carcinoma with arterio-hepatic venous shunts
  • Wenliang Zhu
  • Zhenkang Qiu
  • Huzheng Yan
  • Zhihui Zhong
  • Weiwei Jiang
  • Fujun Zhang
  • Fei Gao
Diagn Interv Radiol 2022; 28: 616-620 DOI: 10.5152/dir.2022.211114
Effect of transjugular intrahepatic portosystemic shunt on transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis
  • Xi Chen
  • Zhen-Kang Qiu
  • Guo-Bao Wang
  • Xin-Lin Chen
  • Fu-Jun Zhang
  • Fei Gao
Diagn Interv Radiol 2021; 27: 671-676 DOI: 10.5152/dir.2021.20358
The position of transarterial chemoembolization with drug-eluting beads and yttrium-90 transarterial radioembolization in patients with hepatocellular carcinoma: Consensus statements from a Delphi-method expert panel in Turkey
  • Ulus Salih Akarca
  • Okan Akhan
  • Sadık Bilgiç
  • Murat Fani Bozkurt
  • Murat Cantaşdemir
  • Tevfik Fikret Çermik
  • Yılmaz Çakaloğlu
  • Özlem Er
  • Erhan Ilgıt
  • Gamze Çapa Kaya
  • Nuriye Özlem Küçük
  • Furuzan Numan
  • Mustafa Parıldar
  • Cüneyt Türkmen
Diagn Interv Radiol 2021; 27: 732-739 DOI: 10.5152/dir.2021.201089
Combination transarterial chemoembolization and microwave ablation vs. microwave ablation monotherapy for hepatocellular carcinomas greater than 3 cm: a comparative study
  • Jason Chiang
  • Pradeep S. Rajendran
  • Frank Hao
  • James Sayre
  • Steven S. Raman
  • David S. K. Lu
  • Justin P. McWilliams
Diagn Interv Radiol 2023; 29: 805-812 DOI: 10.4274/dir.2023.232159 PMID:37665139

Interventional Radiology - Original Article

Inversed albumin-to-globulin ratio and underlying liver disease severity as a prognostic factor for survival in hepatocellular carcinoma patients undergoing transarterial chemoembolization
  • Jinlong Li
  • Zhi Li
  • Shirui Hao
  • Jitao Wang
  • Wei Chen
  • Shoufang Dai
  • Zhenguo Hou
  • Borun Chen
  • Yewei Zhang
  • Dengxiang Liu
Diagn Interv Radiol 2023; 29: 520-528 DOI: 10.5152/dir.2022.211166 PMID:36992824